# Low-Intensity Pulsed Ultrasound in Peripheral and Central Nerve Repair: Mechanisms and Emerging Therapeutic Strategies

**Authors:** Cheng Ma, Saijie Song, Jianwu Dai, He Shen

PMC · DOI: 10.3390/jfb17030113 · 2026-02-26

## TL;DR

Low-intensity pulsed ultrasound is a promising non-invasive therapy for nerve repair, offering benefits over traditional methods by promoting recovery through biological and mechanical effects.

## Contribution

This review provides a comprehensive overview of LIPUS mechanisms, applications, and challenges in peripheral and central nerve repair.

## Key findings

- LIPUS modulates cellular behavior through mechanical cues and biological responses, aiding nerve recovery.
- LIPUS promotes calcium dynamics, inflammation control, and vascular remodeling in nerve injury models.
- Combining LIPUS with biomaterials enhances its therapeutic potential for on-demand drug delivery and electrical signaling.

## Abstract

Low-intensity pulsed ultrasound (LIPUS) has emerged as a versatile, non-invasive physical modality with growing potential in regenerative medicine and neural repair. Advances in ultrasound physics and biomedical engineering have enabled precise spatiotemporal control of acoustic stimulation, positioning therapeutic ultrasound as an alternative to conventional pharmacological and surgical interventions that often suffer from limited targeting and substantial side effects. Unlike high-intensity focused ultrasound, which relies primarily on thermal ablation, LIPUS operates within a low-energy, non-thermal regime and modulates cellular behavior through mechanical cues, mechano-transduction, and downstream biological responses. Accumulating evidence demonstrates that LIPUS regulates calcium dynamics, cytoskeletal remodeling, neurotrophic factor expression, inflammation, myelination, and local vascular remodeling, thereby promoting functional recovery in both peripheral and central nerve injury models. Moreover, the integration of LIPUS with biomaterials, including piezoelectric scaffolds and acoustically responsive drug delivery systems, has expanded its functionality from direct stimulation to on-demand electrical signaling and controlled therapeutic release. Despite these advances, challenges remain regarding parameter standardization, mechanistic consistency, and clinical translation. In this review, we summarize the systems, parameters, and biological mechanisms underlying LIPUS, discuss its applications in peripheral and central nerve injury repair, and highlight emerging strategies and translational barriers toward intelligent, multimodal, and personalized ultrasound-based therapies.

## Full-text entities

- **Genes:** Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 84027], Mbp (myelin basic protein) [NCBI Gene 24547] {aka Mbps}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, Ifng (interferon gamma) [NCBI Gene 25712] {aka IFNG2, If2f}, Ntn1 (netrin 1) [NCBI Gene 114523] {aka netrin-1}, Ngfr (nerve growth factor receptor) [NCBI Gene 24596] {aka LNGFR, RNNGFRR, Tnfrsf16, p75, p75NTR}, Erbb2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 24337] {aka HER2/neu, neu}, Gdnf (glial cell derived neurotrophic factor) [NCBI Gene 25453] {aka gndf}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 25124] {aka DD6G4-4}, Sema3a (semaphorin 3A) [NCBI Gene 29751], CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 29527] {aka COX-2, Cox2, PGHS-2, PHS II, Pghs2}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, c-myc [NCBI Gene 443447], ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 361430] {aka Fam38a, Mib}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56718] {aka Frap1, RAFT1}, F2 (coagulation factor II, thrombin) [NCBI Gene 29251], NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, Sqstm1 (sequestosome 1) [NCBI Gene 113894] {aka Osi, ZIP, ZIP3}, Ntf3 (neurotrophin 3) [NCBI Gene 81737], CyclinD1 [NCBI Gene 100144763], PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, Pik3cg (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma) [NCBI Gene 298947] {aka Pi3k}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Stat6 (signal transducer and activator of transcription 6) [NCBI Gene 362896], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, Cd86 (CD86 molecule) [NCBI Gene 56822] {aka B7-2}, Arg1 (arginase 1) [NCBI Gene 29221], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Camk2g (calcium/calmodulin-dependent protein kinase II gamma) [NCBI Gene 12325] {aka Camkg}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, Cd68 (Cd68 molecule) [NCBI Gene 287435], Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Gdnf (glial cell line derived neurotrophic factor) [NCBI Gene 14573] {aka ATF}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, vimentin [NCBI Gene 101091951], Gap43 (growth associated protein 43) [NCBI Gene 29423] {aka Basp2}, Dcc (DCC netrin 1 receptor) [NCBI Gene 25311], CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, Notch1 (notch receptor 1) [NCBI Gene 25496] {aka NOTCH, TAN1}, GFAP [NCBI Gene 101081938], Nrg1 (neuregulin 1) [NCBI Gene 112400], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, Ngf (nerve growth factor) [NCBI Gene 310738] {aka Ngfb, beta-NGF}, TRPA1 (transient receptor potential cation channel subfamily A member 1) [NCBI Gene 8989] {aka ANKTM1, FEPS, FEPS1, p120}, Cacna1c (calcium channel, voltage-dependent, L type, alpha 1C subunit) [NCBI Gene 12288] {aka Cav1.2, Cchl1a1, D930026N18Rik, MBC, MELC-CC}
- **Diseases:** uterine fibroids (MESH:D007889), inflammation (MESH:D007249), fracture (MESH:D050723), central nervous system diseases (MESH:D002493), TBI (MESH:D000070642), neuronal loss (MESH:D009410), sciatic nerve crush injury (MESH:D000071576), ischemic cardiomyopathy (MESH:D009202), vascular dementia (MESH:D015140), neurological diseases (MESH:D020271), neurotoxicity (MESH:D020258), PNI (MESH:D059348), necrosis (MESH:D009336), Parkinson's (MESH:D010300), Neuroinflammatory (MESH:D000090862), SCI (MESH:D013119), HIFU (MESH:C000657744), postoperative pain (MESH:D010149), AD (MESH:D000544), mandibular bone defects (MESH:D008336), LIPUS (MESH:D009800), demyelination (MESH:D003711), tumor (MESH:D009369), Central Nerve Injury (MESH:D000080902), hypoxia (MESH:D000860), intracerebral hemorrhage (MESH:D002543), injury to (MESH:D014947), sciatic nerve transection or compression (MESH:D009408), white matter injury (MESH:D056784), infection (MESH:D007239), nerve crush (MESH:D003444)
- **Chemicals:** nifedipine (MESH:D009543), RA (MESH:D014212), glucose (MESH:D005947), gold (MESH:D006046), hyaluronan (MESH:D006820), coenzyme Q10 (MESH:C024989), LPS (MESH:D008070), chitosan (MESH:D048271), Heparin (MESH:D006493), Evans blue (MESH:D005070), polyethylene glycol (MESH:D011092), PLA (MESH:C033616), polycaprolactone (MESH:C016240), H2O2 (MESH:D006861), oxygen (MESH:D010100), CUR (-), reactive oxygen species (MESH:D017382), polymer (MESH:D011108), NO (MESH:D009569), calcium (MESH:D002118), pNIPAM (MESH:C052970), curcumin (MESH:D003474)
- **Species:** Ovis aries (domestic sheep, species) [taxon 9940], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481), RSC96 — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_4694), BV2 — Mus musculus (Mouse), Transformed cell line (CVCL_0182)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027937/full.md

---
Source: https://tomesphere.com/paper/PMC13027937